Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome

[1]  Arvind Bagga,et al.  Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  L. Monnens,et al.  Is biopsy required prior to cyclophosphamide in steroid-sensitive nephrotic syndrome? , 2003, Clinical nephrology.

[3]  J. Flynn,et al.  Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome , 2003, Pediatric Nephrology.

[4]  A. Schwarz,et al.  New aspects of the treatment of nephrotic syndrome. , 2001, Journal of the American Society of Nephrology : JASN.

[5]  J. Tobin,et al.  Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. , 1997, Journal of the American Society of Nephrology : JASN.

[6]  P. Halloran,et al.  Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. , 1997, Transplantation.

[7]  A. Allison,et al.  Immunosuppressive and other Effects of Mycophenolic Acid and an Ester Prodrug, Mycophenolate Mofetil , 1993, Immunological reviews.

[8]  G. Sármay,et al.  B‐cell Activation‐Induced Phosphorylation of FcγRII: A Possible Prerequisite of Proteolytic Receptor Release , 1992, Immunological reviews.

[9]  H. L. Barnett.  International study of kidney disease in children. , 1979, Nihon Jinzo Gakkai shi.

[10]  Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the International Study of Kidney Disease in Children. , 1978, Kidney international.